International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 386-391, 1 June 2005

Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Received 4 June 2004; received in revised form 16 September 2004; accepted 22 September 2004. published online 17 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by a grant from Massachusetts Department of Public Health, The NCI/AVON Supplement to NCI SPORE award, P50 CA 89393, and Grants CA 50628 and CA 21239 from the National Cancer Institute, Department of Health and Human Services.

PII: S0360-3016(04)02696-3

doi:10.1016/j.ijrobp.2004.09.044

International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 386-391, 1 June 2005

Article Tools